Bausch & Lomb looks to protect patents in eyedrop lawsuit
26-10-2021
Bausch settles $300m antitrust case over diabetes drug price hikes
13-09-2021
OleksandrShnuryk / Shutterstock.com
Nutritional supplements manufacturer Pharmavite has filed an antitrust suit against Bausch & Lomb and GlaxoSmithKline (GSK), claiming that they are filing sham patent litigation related to its “PreserVision” products
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pharmavite, Bausch & Lomb, GSK, patents, monopoly, generics
